mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |